Rocket Lab USA is in the midst of its most ambitious transformation yet — but the stock chart tells a story of doubt. While the company moves to acquire Iridium Communications for roughly $8 billion and expand into a vertically integrated space-infrastructure player, its shares have tumbled 27% over the past month and sit nearly 50% below the 52-week high of $151.00 reached in May. Wednesday’s close at $76.20 left the stock less than $2 above its 200-day moving average of $78.11 — a level that often serves as a final line of technical support before deeper losses.
The disconnect between strategic ambition and market reception defines Rocket Lab’s current moment. Announced in late June, the Iridium deal would give the company an established satellite constellation, spectrum rights, and recurring revenue from global communications services — shifting the business model from transactional launch fees to annuity-like infrastructure ownership. But the acquisition remains subject to regulatory and shareholder approval, and the market initially knocked the stock down 5.5% on the news. That reaction cut against the bullish analyst consensus, underscoring how investors are weighing the promise of platform economics against the reality of execution risk.
CEO Peter Beck has framed the strategy as a natural evolution. Rocket Lab is no longer merely a launch provider for small satellites; it now competes in Pentagon programs such as the NSSL Phase 3 Lane 1 category, which gives it access to sensitive national-security missions previously dominated by larger primes. The VICTUS-HAZE mission for the US Space Force demonstrated exactly this capability — designing, building, and launching an on-orbit inspection satellite under a tight, tactically responsive timeline. At the same time, the company is pressing forward with its next-generation Neutron rocket, having completed a full-duration static fire of the second stage. First flight is targeted for the fourth quarter of 2026, though development costs have already exceeded original estimates, and a January test-stand accident caused delays.
Should investors sell immediately? Or is it worth buying Rocket Lab USA?
The bull case centres on the combined revenue potential of Iridium’s communications network and Neutron’s pricing power. Rocket Lab’s order book has expanded meaningfully in the first half of the year, and analysts point to growing customer commitments across both government and commercial segments. The bear case, however, piles execution risk atop integration risk. Neutron has yet to fly, and any further technical setbacks would compound the capital burn — the company remains unprofitable and capital-intensive. The Iridium integration itself could also prove more expensive or slower than expected, adding complexity just as Rocket Lab is trying to prove its platform thesis.
Technical indicators reflect a market still searching for direction. The 30-day relative strength index sits at 34.5, flirting with oversold territory, while the annualised 30-day volatility has surged past 95%. With the stock trading nearly 30% below its 50-day average of $107.93, near-term momentum has clearly broken. Still, the year-to-date gain of 59.78% serves as a reminder of how violently shares can swing in either direction.
The next milestones are clear: further qualification tests for Neutron ahead of its debut, and updates on the regulatory and shareholder approvals for the Iridium transaction. If the test campaign proceeds without incident and the deal financing solidifies, the stock could regain its footing — especially with the RSI already signalling a potential bounce. But if technical problems resurface, as they have before, or if the Iridium integration reveals unexpected friction, the bearish narrative will likely harden. For now, Rocket Lab is selling a story of vertical control and recurring income. The market is still deciding whether to buy it.
Ad
Rocket Lab USA Stock: Buy or Sell?! New Rocket Lab USA Analysis from July 16 delivers the answer:
The latest Rocket Lab USA figures speak for themselves: Urgent action needed for Rocket Lab USA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 16.
Rocket Lab USA: Buy or sell? Read more here...










